CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 3 filers reported holding CASI PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $59,000 | +490.0% | 73,117 | +1571.6% | 0.00% | – |
| Q1 2021 | $10,000 | -71.4% | 4,374 | -62.9% | 0.00% | – |
| Q4 2020 | $35,000 | +600.0% | 11,781 | +271.1% | 0.00% | – |
| Q3 2020 | $5,000 | -72.2% | 3,175 | -57.0% | 0.00% | – |
| Q2 2020 | $18,000 | -35.7% | 7,385 | -46.0% | 0.00% | – |
| Q1 2020 | $28,000 | -9.7% | 13,674 | +35.3% | 0.00% | – |
| Q4 2019 | $31,000 | +34.8% | 10,108 | +46.6% | 0.00% | – |
| Q3 2019 | $23,000 | -48.9% | 6,893 | -50.8% | 0.00% | – |
| Q2 2019 | $45,000 | +18.4% | 14,008 | +4.5% | 0.00% | – |
| Q1 2019 | $38,000 | -24.0% | 13,408 | +9.7% | 0.00% | – |
| Q4 2018 | $50,000 | -21.9% | 12,223 | -10.8% | 0.00% | – |
| Q3 2018 | $64,000 | +433.3% | 13,700 | +19.1% | 0.00% | – |
| Q3 2015 | $12,000 | -42.9% | 11,499 | 0.0% | 0.00% | – |
| Q2 2015 | $21,000 | +23.5% | 11,499 | 0.0% | 0.00% | – |
| Q1 2015 | $17,000 | +13.3% | 11,499 | 0.0% | 0.00% | – |
| Q4 2014 | $15,000 | -28.6% | 11,499 | 0.0% | 0.00% | – |
| Q3 2014 | $21,000 | – | 11,499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $23,522,000 | 27.18% |
| Consonance Capital Management LP | 7,576,431 | $22,350,000 | 2.09% |
| Wellington Shields & Co., LLC | 1,812,769 | $5,348,000 | 1.92% |
| Wellington Shields Capital Management, LLC | 2,071,765 | $6,112,000 | 0.82% |
| Ikarian Capital, LLC | 1,268,154 | $3,741,000 | 0.16% |
| Sio Capital Management, LLC | 203,432 | $600,000 | 0.12% |
| Zebra Capital Management LLC | 11,182 | $33,000 | 0.04% |
| FEDERATED HERMES, INC. | 7,000,000 | $20,650,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,146 | $154,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 161,949 | $478,000 | 0.02% |